Paper TrailKOREA
Why Korean and U.S. stocks moved, checked against filings

AAON Up 31% in Two Days Despite a Restatement: What the 8-K Says

AAON rose 31.2% in two days on record quarterly sales and a raised outlook, but the same 8-K carried a non-reliance notice (Item 4.02) on earlier financials. Csquare rose on earnings and Acadia on patent-appeal coverage.

AAON Up 31% in Two Days Despite a Restatement: What the 8-K Says

Selection: three stocks that closed up 10% or more in the Nov. 10 regular session (U.S. time). All three have a reason confirmed by filings or news; two are backed by SEC EDGAR 8-K filings. Data as of 07:06 KST on Nov. 11.

Seoul — U.S. stocks fell on Nov. 10, with the S&P 500 down 0.38%, the Nasdaq Composite down 0.74% and the Russell 2000 small-cap index down 0.68%, yet AAON (AAON) gained 19.31% and Csquare (CSQR) gained 14.73% on data-center-driven earnings. Both have filings with the U.S. Securities and Exchange Commission (SEC) behind the earnings. Acadia Pharmaceuticals (ACAD) rose 10.79% after a patent appeal hearing, but the company filed nothing on it and only news reports cover the move.

At a glance

Stock Why it rose Nature of the news Evidence Heat What to check next
AAON (AAON) +19.31% Record Q3 sales and raised guidance (restatement notice in the same filing) Substantive, ongoing Filing confirmed (8-K 2.02, 4.02, 7.01) 0/4 normal Further filings after the restatement; whether the two-day gain holds
Csquare (CSQR) +14.73% Q3 revenue growth, strong bookings, raised profit outlook per reports Substantive, ongoing (figures per news) Filing confirmed (8-K 2.02) plus news 0/4 normal Raised-outlook figures in Exhibit 99.1; size of the loss
Acadia Pharmaceuticals (ACAD) +10.79% Rebound after patent appeal hearing Expectation News only (no related 8-K) 0/4 normal Timing of the appeals court ruling and any company filing

Note: closes and moves are for the Nov. 10 regular session, and the heat check uses that day's close. Filing tone: AAON positive (earnings) and caution (restatement), Csquare positive (earnings), Acadia neutral (13G).

AAON rose 31% in two days on record quarterly sales, with a restatement notice in the same filing

AAON recent price and volume

AAON rose on the third-quarter results and raised full-year outlook it announced on Nov. 9. According to an 8-K (a current report of major events) filed with the SEC, the company announced third-quarter results and backlog (Item 2.02). The 8-K itself carries no figures and attaches a press release as Exhibit 99.1. TradingNEWS reported record quarterly sales of $707.4 million and a raised guide, and a Yahoo headline said data-center cooling sales jumped 218%. The stock gained 9.93% on Nov. 9 and 19.31% on Nov. 10, or 31.2% over the two days.

The same 8-K also contains Item 4.02, a notice that previously issued financial statements should not be relied on. It says management, under the Audit Committee's oversight, concluded on Nov. 3 that earlier unaudited condensed consolidated financial statements needed to be revisited, and amended quarterly reports (10-Q/A) for the first and second quarters were filed the same day. Yahoo summarized this as a restatement of the first two quarters plus a disclosed internal-control matter. Separately, an 8-K on Nov. 10 (Item 8.01) declared a regular quarterly dividend of $0.10 per share ($0.40 a year), payable Dec. 17, which is routine and not a reason for the rally.

The heat check shows 0 of 4 signals. Volume was 3.7 times the 20-day average (about $376.7 million traded, 6.1% of a market cap of roughly $6.185 billion), but RSI was 49.8, the price was 6.8% above the 20-day average and the five-day move was +8.6%. The stock sits at 22% of its 52-week range, 49.4% below the 52-week high and 22.4% below its 200-day average. It passes 4 of 6 earnings-strength checks (P/E 39.5; revenue growth of 84.1% is on the checklist's own basis, not the quarterly figure in news reports). The shares had fallen 15.68% on Nov. 4 and 6.58% on Nov. 5 before the 31.2% two-day rise, so part of the move may be a short-term rebound.

Two things show whether this holds: whether the company files anything new on internal controls or further corrections after the restatement, and whether volume stays near three times normal on Nov. 11.

Csquare rose 14.7% as earnings pointed to data-center demand

Csquare recent price and volume

Csquare rose on third-quarter results announced Nov. 9. Its 8-K (Item 2.02) only attaches a press release without figures, but scanx.trade reported revenue up 25.6% year on year to $302.3 million. Benzinga reported that data-center demand drove a revenue beat, strong bookings and a raised profit outlook, and GuruFocus and Investing.com reported that TD Cowen and BMO raised price targets. The two-day gain is 22.2%.

The company is still loss-making. It fails the profitability and debt checks and passes only revenue growth, 1 of 4, and a GuruFocus headline said revenue beat expectations despite losses. The heat check shows 0 of 4 signals: volume was 3.1 times normal (about $116.1 million traded, 4.0% of a roughly $2.92 billion market cap), the price was 14.8% above its 20-day average and RSI was 52.8. It sits at 44% of its 52-week range and 23.8% below the high.

Two things to check: the specific figures behind the raised profit outlook in the press release, and how the loss and debt burden look in the 10-Q filed Nov. 10.

Acadia Pharmaceuticals rebounded after a patent appeal hearing, with no company filing

Acadia Pharmaceuticals recent price and volume

Acadia's 10.79% gain is explained by news reports, not a filing. Oral arguments in its Nuplazid formulation patent appeal were held at the U.S. Court of Appeals for the Federal Circuit on Nov. 10, and the company commented on them (a company release carried by Yahoo). Seeking Alpha reported that the stock gained after the hearing. The headlines do not say what was argued or which way the court leans. No 8-K covers the hearing; the latest 8-K is the Nov. 4 earnings report (Item 2.02). A SCHEDULE 13G filed Nov. 10 reports that one holder owns 7.65 million shares (Stock Titan), a passive holding report rather than an activist one.

The move retraces part of a 22.28% drop on the previous session. The close went from $21.23 to $16.50, then to $18.28. After the drop, outlets noted that sales rose while the stock fell (Yahoo). The heat check shows 0 of 4 signals (RSI 40.2, 8.6% below the 20-day average, volume 2.6 times normal). The stock is at 13% of its 52-week range, 40.2% below the high and 22.0% below its 200-day average. It passes all 6 earnings-strength checks (P/E 8.6, revenue growth 22.8% on the checklist basis).

Whether this lasts depends on when the appeals court rules and whether the company reports the ruling in an 8-K. Until then the move is a reaction to hearing coverage, so it is also worth seeing whether trading value holds on Nov. 11.

Filings and reports reviewed

  • 2026-11-10 AAON 8-K (Items 8.01, 9.01, quarterly dividend): https://www.sec.gov/Archives/edgar/data/824142/000082414226000090/aaon-20261110.htm
  • 2026-11-09 AAON 8-K (Items 2.02, 4.02, 7.01, results and non-reliance notice): https://www.sec.gov/Archives/edgar/data/824142/000082414226000083/aaon-20261109.htm
  • 2026-11-09 AAON 10-Q and two 10-Q/As (periods ended Sept. 30, June 30 and March 31)
  • 2026-11-09 Csquare 8-K (Items 2.02, 9.01): https://www.sec.gov/Archives/edgar/data/2105398/000210539826000007/csqr-20261109.htm
  • 2026-11-10 Csquare 10-Q: https://www.sec.gov/Archives/edgar/data/2105398/000210539826000008/csqr-20260930.htm
  • 2026-11-04 Acadia 8-K (Item 2.02): https://www.sec.gov/Archives/edgar/data/1070494/000119312526447276/acad-20261104.htm
  • 2026-11-10 Acadia SCHEDULE 13G
  • News: TradingNEWS and Yahoo (AAON); Benzinga, scanx.trade and GuruFocus (Csquare); Seeking Alpha and Yahoo (Acadia), Nov. 10-11

FAQ

Why did these stocks rise? AAON on Q3 results and a raised outlook, Csquare on Q3 results, and Acadia on coverage of a patent appeal hearing.

Which filings back it up? AAON's Nov. 9 8-K (Items 2.02, 4.02, 7.01) and Csquare's Nov. 9 8-K (Item 2.02). Nothing filed explains Acadia's move.

What should I check next? For AAON, further filings after the restatement and the Dec. 17 dividend payment (record date Nov. 25). For Acadia, the timing of the appeals court ruling. No scheduled date is confirmed for Csquare.

What happened to the stocks we covered last time

These are the eight stocks from the Nov. 5-7 articles, with the verdict then and the move from the article-date close to the Nov. 10 close.

Stock Verdict then Move since
Firefly Aerospace (FLY) News +14.2%
AppLovin (APP) Earnings +11.1%
Rhythm Pharmaceuticals (RYTM) News +3.0%
Kyndryl (KD) Earnings +2.6%
JFrog (FROG) Earnings +2.5%
Karman Holdings (KRMN) Earnings -3.7%
ADMA Biologics (ADMA) Earnings -4.1%
Encore Capital Group (ECPG) Earnings -14.4%

Of the six tagged 'Earnings', three rose and three fell, while both tagged 'News' rose. The sample is too small to read as a pattern by verdict.

FAQ

Why did AAON stock go up?

Record Q3 sales and raised guidance (restatement notice in the same filing). Evidence: Filing confirmed (8-K 2.02, 4.02, 7.01). What to check next: 0/4 normal.

Why did Csquare stock go up?

Q3 revenue growth, strong bookings, raised profit outlook per reports. Evidence: Filing confirmed (8-K 2.02) plus news. What to check next: 0/4 normal.

Why did Acadia Pharmaceuticals stock go up?

Rebound after patent appeal hearing. Evidence: News only (no related 8-K). What to check next: 0/4 normal.

← Latest · Daily movers archive